APC and breast carcinoma: Adenomatous polyposis coli (APC) and retinoic acid receptors-2 (RARb2) methylated promoters were discovered in 93.4% and 95.6% of blood samples from females having breast cancer, respectively, but not in healthy people (Swellam et al., 2015).